Edition:
United States

Health News

Photo

Allergan ruling casts doubt on tribal patent strategy 6:06pm EDT

A U.S. judge’s ruling on Monday invalidating Allergan Plc's patents on its blockbuster $1.5 billion dry-eye medicine, Restasis, has cast doubt on the company's novel strategy to enlist a Native American tribe to help shield those patents from challenge by generic drugmakers, legal experts said.

More Headlines

Should donor sex influence blood transfusion practices?

(Reuters Health) - Sick or injured men who receive blood transfusions may be more likely to die if their donor was a woman who has been pregnant in the past, a new study suggests.

4:04pm EDT
Photo

UnitedHealth sees growth in 2018, opportunities in Trump plans

UnitedHealth Group Inc, the largest U.S. health insurer, said earnings will grow 13 to 16 percent in 2018 as medical costs remain low, and that it expects to benefit from new insurance products backed by U.S. President Donald Trump.

2:22pm EDT

Frailty tied to higher risk of complications with common surgeries

(Reuters Health) - Frail patients are more likely to have serious complications after elective outpatient surgery than people who are healthier and stronger, a recent study suggests.

4:55pm EDT

Transenterix won't compete head-on with Intuitive Surgical: CEO

Transenterix Inc's chief executive played down on Tuesday the threat posed by his company's surgical robotic system to market leader Intuitive Surgical Inc, saying he did not expect the two to compete head on.

Tech 12:53pm EDT

Health Watch Graphics